According to Zhang et al. (2019), elevated PLCβ3 mRNA levels correlate with poor overall survival rates in NSCLC patients, and correlates with poor prognosis in adenocarcinoma cases [62]. This evidence concerns the gene PLCB3 and adenocarcinoma.